Production Linked Incentive (PLI) Scheme for Pharmaceuticals (2026): Benefit, Eligibility & Online Application
The PLI Scheme for Pharmaceuticals, with a financial outlay of ₹15,000 Crore, aims to enhance India’s manufacturing capabilities in high-value biopharmaceuticals, complex generic drugs, patented drugs, in-vitro diagnostic medical devices, and active pharmaceutical ingredients (APIs).
- Nodal Ministry / Authority:
- Ministry of Chemicals and Fertilizers
- Subsidy / Financial Benefit:
- Group-wise budgetary allocation (Total outlay ₹15,000 Crore)
- Target Beneficiary:
- Pharmaceutical Companies & Biotech Enterprises
- Geographic Coverage & Mode:
- Central · Online via DoP Portal
- Official Government Portal:
- Department of Pharmaceuticals
Detailed Scheme Benefits & Assistance Structure
Incentives ranging from 3% to 10% on incremental sales of eligible pharmaceutical products for 6 financial years across Groups A, B, and C.
Eligibility Criteria (पात्रता मापदंड)
Pharmaceutical manufacturing entities registered in India categorized into Group A (global sales >₹5,000 Cr), Group B (sales ₹500–5,000 Cr), and Group C (MSMEs with sales <₹500 Cr).
Required Documents (आवश्यक दस्तावेज)
- Manufacturing License from CDSCO / State FDA
- Audited Annual Accounts and CA Turnover Certificates
- Drug Master File (DMF) / Regulatory Filing Approvals
- Investment Invoices for Cleanroom and Manufacturing Machinery
How to Apply Online (आवेदन प्रक्रिया)
Applications submitted online via the Department of Pharmaceuticals PLI portal (pharmaceuticals.gov.in). Annual performance claims are audited by SIDBI as Project Management Agency.
Verification Note: Empanelled under three groups to guarantee MSME pharma inclusion alongside global manufacturers.